Topic
Dr. Reddy’s
Dr. Reddy’s Semaglutide Injection Wins Health Canada Approval with OneSource as CDMO Partner
OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE) announced that partner Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE:…
Dr Reddy’s launches Hevaxin, a novel recombinant Hepatitis E vaccine in India
The clinical studies have demonstrated that Hevaxin provides protection, supports long‐lasting immunity Dr Reddy’s Laboratories announced the launch of Hevaxin,…
Dr Reddy’s launches drug-free migraine management device Nerivio in Europe
In India, Nerivio is supported by Dr Reddy’s unique patient support programme called ‘M-Free’ Dr Reddy’s Laboratories announced the launch…
Lupin appoints Dr Ranjana Pathak as Chief Quality Officer
Dr Pathak will oversee all aspects of quality and regulatory compliance for Lupin’s global operations Lupin announced the appointment of…
IPA’s 8th Global Pharmaceutical Quality Summit concludes in Mumbai
The focus of the event was on patient centricity and the future of manufacturing and quality The Indian Pharmaceutical Alliance…
Pharma majors collaborate for clinical trial of Molnupiravir for COVID-19 treatment
The five pharma companies will jointly sponsor, supervise and monitor the clinical trial in India Cipla, Dr Reddy’s, Emcure, Sun…
Drug makers told to ramp up remdesivir production: Govt
The direction comes against reports of shortages of the critical drug The government said that all seven manufacturers of remdesivir…
Pfizer moves US court against Aurobindo Pharma, Dr Reddy’s
According to Pfizer, the Indian drug makers were planning separately to come out with generic versions of its blockbuster multi-billion…
Dr. Reddy’s Laboratories to buy branded generics business of Wockhardt
Hyderabad: Dr. Reddy’s Laboratories has acquire select divisions of Wockhardt's branded generics business in India and a few other international…